SCM
ZVSAW

Saba Capital Management’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

Saba Capital Management’s Portfolio ZVSAW Stock Details ZVSAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-86,247
Closed -$10K – 1070
2022
Q3 		$10K Hold
86,247
– – ﹤0.01% 1019
2022
Q2 		$8K Hold
86,247
– – ﹤0.01% 1063
2022
Q1 		$15K Buy
+86,247
New +$17.5K ﹤0.01% 934

Saba Capital Management's ZVSAW Position: Q4 2022 in Review

Saba Capital Management sold out of ZyVersa Therapeutics, Inc. Warrants (ZVSAW) in Q4 2022, closing a stake of 86,247 shares — an estimated $10K sold.

Saba Capital Management first reported a position in ZVSAW in Q1 2022 and held it in 3 quarters. The position peaked at $15K in Q1 2022. 1 fund tracked by Wall St. Rank holds ZVSAW as of Q4 2022.

  • Saba Capital Management reported no remaining ZyVersa Therapeutics, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
  • Saba Capital Management sold 86,247 ZyVersa Therapeutics, Inc. Warrants shares in Q4 2022, an estimated $10K.
  • Saba Capital Management first reported a position in ZyVersa Therapeutics, Inc. Warrants in Q1 2022 and held it in 3 quarters.
  • Saba Capital Management's ZyVersa Therapeutics, Inc. Warrants position peaked at $15K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held ZyVersa Therapeutics, Inc. Warrants as of Q4 2022.

Based on Saba Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.